2024 Q3 Form 10-Q Financial Statement

#000095017024094153 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $8.630M $7.628M
YoY Change -21.17% -40.71%
Cost Of Revenue $15.95M $14.53M
YoY Change -14.66% -25.23%
Gross Profit -$7.315M -$6.903M
YoY Change -5.45% 5.1%
Gross Profit Margin -84.76% -90.5%
Selling, General & Admin $6.861M $6.752M
YoY Change -58.56% -59.91%
% of Gross Profit
Research & Development $4.580M $5.109M
YoY Change -33.46% -33.73%
% of Gross Profit
Depreciation & Amortization $7.376M $7.438M
YoY Change 1.6% 3.69%
% of Gross Profit
Operating Expenses $11.44M $11.86M
YoY Change -51.19% -51.69%
Operating Profit -$18.82M -$19.33M
YoY Change -39.75% -37.89%
Interest Expense -$9.837M -$3.330M
YoY Change 16.41% -58.78%
% of Operating Profit
Other Income/Expense, Net -$3.016M -$3.330M
YoY Change -64.32% -59.3%
Pretax Income -$21.84M -$22.66M
YoY Change -44.98% -42.35%
Income Tax $2.000K $2.000K
% Of Pretax Income
Net Earnings -$21.84M -$22.66M
YoY Change -45.62% -42.25%
Net Earnings / Revenue -253.06% -297.08%
Basic Earnings Per Share -$0.18 -$0.19
Diluted Earnings Per Share -$0.18 -$0.19
COMMON SHARES
Basic Shares Outstanding 120.2M 116.4M
Diluted Shares Outstanding 119.7M 116.5M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.19M $40.25M
YoY Change -71.33% -55.65%
Cash & Equivalents $22.19M $40.25M
Short-Term Investments
Other Short-Term Assets $5.395M $5.907M
YoY Change 12.4% 8.56%
Inventory $26.04M $26.28M
Prepaid Expenses $5.395M $5.907M
Receivables $11.75M $10.93M
Other Receivables $125.0K $580.0K
Total Short-Term Assets $69.87M $86.87M
YoY Change -45.01% -40.24%
LONG-TERM ASSETS
Property, Plant & Equipment $430.2M $434.3M
YoY Change -4.36% -4.38%
Goodwill
YoY Change
Intangibles $75.76M $76.42M
YoY Change -3.68% -3.68%
Long-Term Investments
YoY Change
Other Assets $3.180M $4.218M
YoY Change 819.08% 1126.16%
Total Long-Term Assets $573.9M $579.7M
YoY Change -3.37% -3.21%
TOTAL ASSETS
Total Short-Term Assets $69.87M $86.87M
Total Long-Term Assets $573.9M $579.7M
Total Assets $643.8M $666.5M
YoY Change -10.71% -10.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.542M $2.880M
YoY Change 16.19% -19.06%
Accrued Expenses $6.131M $4.781M
YoY Change 3.93% -4.09%
Deferred Revenue $914.0K $850.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.021M $6.976M
YoY Change 408.53% 277.69%
Total Short-Term Liabilities $21.33M $19.21M
YoY Change 44.46% 31.56%
LONG-TERM LIABILITIES
Long-Term Debt $381.9M $386.9M
YoY Change 0.84% 2.9%
Other Long-Term Liabilities $1.238M $1.017M
YoY Change 7.37% -6.09%
Total Long-Term Liabilities $1.238M $1.017M
YoY Change 7.37% -6.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.33M $19.21M
Total Long-Term Liabilities $1.238M $1.017M
Total Liabilities $432.2M $432.5M
YoY Change 3.72% 4.48%
SHAREHOLDERS EQUITY
Retained Earnings -$525.9M -$504.0M
YoY Change 26.81% 34.58%
Common Stock $13.00K $12.00K
YoY Change 30.0% 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $211.6M $234.0M
YoY Change
Total Liabilities & Shareholders Equity $643.8M $666.5M
YoY Change -10.71% -10.44%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$21.84M -$22.66M
YoY Change -45.62% -42.25%
Depreciation, Depletion And Amortization $7.376M $7.438M
YoY Change 1.6% 3.69%
Cash From Operating Activities -$14.50M -$18.97M
YoY Change 42.43% 24.1%
INVESTING ACTIVITIES
Capital Expenditures $3.716M $1.800M
YoY Change 38.66% -72.9%
Acquisitions
YoY Change
Other Investing Activities $1.167M
YoY Change 5735.0%
Cash From Investing Activities -$2.549M -$1.800M
YoY Change -4.17% -72.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.070M 3.611M
YoY Change 98.15% -155.47%
NET CHANGE
Cash From Operating Activities -14.50M -18.97M
Cash From Investing Activities -2.549M -1.800M
Cash From Financing Activities -1.070M 3.611M
Net Change In Cash -18.12M -17.16M
YoY Change 35.41% -39.66%
FREE CASH FLOW
Cash From Operating Activities -$14.50M -$18.97M
Capital Expenditures $3.716M $1.800M
Free Cash Flow -$18.22M -$20.77M
YoY Change 41.64% -5.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116608522
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001779020
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#Liabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39280
dei Entity Registrant Name
EntityRegistrantName
DANIMER SCIENTIFIC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1924518
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Industrial Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Bainbridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
39817
dei City Area Code
CityAreaCode
229
dei Local Phone Number
LocalPhoneNumber
243-7075
dei Security12b Title
Security12bTitle
Class A Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
DNMR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
120170109
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40254000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59170000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10928000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15227000
CY2024Q2 us-gaap Other Receivables
OtherReceivables
580000
CY2023Q4 us-gaap Other Receivables
OtherReceivables
652000
CY2024Q2 us-gaap Inventory Net
InventoryNet
26277000
CY2023Q4 us-gaap Inventory Net
InventoryNet
25270000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5907000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4714000
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2928000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3005000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
86874000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
108038000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
434257000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
445153000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76415000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
77790000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19163000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19160000
CY2024Q2 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2023Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14167000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14334000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4218000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2210000
CY2024Q2 us-gaap Assets
Assets
666540000
CY2023Q4 us-gaap Assets
Assets
698131000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2880000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5292000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4781000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4726000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
850000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3723000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6976000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1368000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
19210000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15723000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21461000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21927000
CY2024Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
386910000
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
381436000
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3914000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1017000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1020000
CY2024Q2 us-gaap Liabilities
Liabilities
432512000
CY2023Q4 us-gaap Liabilities
Liabilities
420111000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
116608522
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116608522
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102832103
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102832103
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
12000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
738061000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
732131000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-504045000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-454121000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
234028000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278020000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
666540000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
698131000
CY2024Q2 us-gaap Revenues
Revenues
7628000
CY2023Q2 us-gaap Revenues
Revenues
12865000
us-gaap Revenues
Revenues
17852000
us-gaap Revenues
Revenues
24791000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
14531000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
19433000
us-gaap Cost Of Revenue
CostOfRevenue
31066000
us-gaap Cost Of Revenue
CostOfRevenue
37642000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6752000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16844000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13621000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35543000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5109000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7709000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10451000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14784000
CY2024Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-565000
CY2023Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-565000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-170000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
26957000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
43986000
us-gaap Costs And Expenses
CostsAndExpenses
55703000
us-gaap Costs And Expenses
CostsAndExpenses
88139000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19329000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31121000
us-gaap Operating Income Loss
OperatingIncomeLoss
-37851000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63348000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5742000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1083000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5841000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
33000
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9072000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9162000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17910000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12548000
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-102000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-102000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3330000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8181000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12069000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12683000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22659000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39302000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49920000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76031000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-151000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-22661000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39241000
us-gaap Net Income Loss
NetIncomeLoss
-49924000
us-gaap Net Income Loss
NetIncomeLoss
-75880000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116465086
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116465086
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101938376
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101938376
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110114660
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110114660
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101917585
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101917585
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
234028000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
330284000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
234028000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
330284000
us-gaap Profit Loss
ProfitLoss
-49924000
us-gaap Profit Loss
ProfitLoss
-75880000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14969000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14752000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5841000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
33000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5821000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3485000
us-gaap Share Based Compensation
ShareBasedCompensation
1169000
us-gaap Share Based Compensation
ShareBasedCompensation
27974000
dnmr Warrant Issuance Costs
WarrantIssuanceCosts
867000
dnmr Warrant Issuance Costs
WarrantIssuanceCosts
0
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-565000
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-170000
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-437000
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
948000
dnmr Inventory Reserves
InventoryReserves
-313000
dnmr Inventory Reserves
InventoryReserves
464000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-83000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-237000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-155000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1046000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3863000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5939000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-74000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-38000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
694000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2383000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
751000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1130000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
185000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
959000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-70000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
120000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2078000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2377000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
227000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
600000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-4000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
636000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-150000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
875000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31961000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21151000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3770000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23041000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3770000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23041000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
8883000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
dnmr Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs
ProceedsCostsFromIssuanceOfCommonStockNetOfIssuanceCosts
4658000
dnmr Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs
ProceedsCostsFromIssuanceOfCommonStockNetOfIssuanceCosts
0
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
11326000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
130000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7227000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11744000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1095000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33295000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
118000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
129000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
61000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16648000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85029000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19083000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
40837000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73504000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64401000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54421000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105238000
us-gaap Interest Paid Net
InterestPaidNet
13698000
us-gaap Interest Paid Net
InterestPaidNet
9530000
us-gaap Operating Lease Payments
OperatingLeasePayments
1860000
us-gaap Operating Lease Payments
OperatingLeasePayments
1858000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40300000
CY2024Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
27400000
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
11762000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10867000
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1436000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
546000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13079000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13857000
CY2024Q2 us-gaap Inventory Net
InventoryNet
26277000
CY2023Q4 us-gaap Inventory Net
InventoryNet
25270000
CY2024Q2 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
9000000
CY2023Q4 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
7600000
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
600000
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
900000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
516391000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
514715000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
82134000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69562000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
434257000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
445153000
CY2024Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7438000
CY2023Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7173000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14969000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14752000
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
204500000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
202998000
CY2024Q2 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
15000000
CY2023Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
15000000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P17Y
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
96605000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
95765000
CY2024Q2 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-3102000
CY2023Q4 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-2838000
CY2024Q2 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
93503000
CY2023Q4 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92927000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20190000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17975000
CY2024Q2 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
73313000
CY2023Q4 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
74952000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76415000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
77790000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2400000
CY2024Q2 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1773000
CY2023Q4 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1692000
CY2024Q2 dnmr Other Accrued Taxes
OtherAccruedTaxes
1223000
CY2023Q4 dnmr Other Accrued Taxes
OtherAccruedTaxes
552000
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
629000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
440000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
406000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
839000
CY2024Q2 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
261000
CY2023Q4 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
350000
CY2024Q2 dnmr Accrued Rebates Current And Non Current
AccruedRebatesCurrentAndNonCurrent
38000
CY2023Q4 dnmr Accrued Rebates Current And Non Current
AccruedRebatesCurrentAndNonCurrent
233000
CY2024Q2 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
25000
CY2023Q4 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
191000
CY2024Q2 dnmr Purchase Accrual
PurchaseAccrual
0
CY2023Q4 dnmr Purchase Accrual
PurchaseAccrual
8000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
426000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
421000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4781000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4726000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
1029000
CY2023Q2 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
951000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
2064000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
1745000
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
422847000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
417462000
CY2024Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
28961000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
34658000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6976000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1368000
CY2024Q2 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
386910000
CY2023Q4 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
381436000
CY2021Q4 dnmr Convertible Senior Notes Due Year
ConvertibleSeniorNotesDueYear
2026
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.79
CY2024Q2 dnmr Warrants Distributed As Dividend
WarrantsDistributedAsDividend
200
CY2024Q2 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2023Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2024Q2 us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
5200000
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0824
CY2024Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0849
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114240921
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102832103
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2024Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2367601
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
13776419
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
133922
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116608522
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58303382
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42163762
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58303382
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42163762
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1100000
CY2024Q2 us-gaap Revenues
Revenues
7628000
CY2023Q2 us-gaap Revenues
Revenues
12865000
us-gaap Revenues
Revenues
17852000
us-gaap Revenues
Revenues
24791000
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
199000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
13666000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1165000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
28609000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9257704
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.27
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y4M17D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4334
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9253370
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.27
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M17D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23199
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9230171
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.28
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M13D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8118263
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M7D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2024Q2 dnmr Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number Of Shares Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfSharesVestedAndExpectedToVest
9230171
CY2024Q2 dnmr Weighted Average Exercise Price Vested And Expected To Vest
WeightedAverageExercisePriceVestedAndExpectedToVest
11.28
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M13D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2024Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
35700000
CY2024Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
51900000
dnmr Royalty Per Share
RoyaltyPerShare
0.05
dnmr Weights Of Pha Sold
WeightsOfPhaSold
500000
dnmr Decrease Royalty Per Share
DecreaseRoyaltyPerShare
0.025
dnmr Prepaid Royalties Loss On Forfeiture
PrepaidRoyaltiesLossOnForfeiture
500000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-094153-index-headers.html Edgar Link pending
0000950170-24-094153-index.html Edgar Link pending
0000950170-24-094153.txt Edgar Link pending
0000950170-24-094153-xbrl.zip Edgar Link pending
dnmr-20240630.htm Edgar Link pending
dnmr-20240630.xsd Edgar Link pending
dnmr-ex10_5.htm Edgar Link pending
dnmr-ex31_1.htm Edgar Link pending
dnmr-ex31_2.htm Edgar Link pending
dnmr-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
dnmr-20240630_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable